Results 191 to 200 of about 178,517 (322)

Highly efficient purification of protein complexes from mammalian cells using a novel streptavidin‐binding peptide and hexahistidine tandem tag system: Application to Bruton's tyrosine kinase [PDF]

, 2010
Yifeng Li, Sarah Franklin, Michael J. Zhang, Thomas M. Vondriska   +3 more
openalex   +1 more source

A comparison of DNA repair pathways to achieve a site-specific gene modification of the Bruton's tyrosine kinase gene [PDF]

, 2021
David Gray, Jasmine Santos, Alexandra Keir, Isaac Villegas, Simon Maddock, Edward C. Trope, Joseph Long, Caroline Y. Kuo   +7 more
openalex   +1 more source

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies

American Journal of Ophthalmology Case Reports
Purpose: To report two new cases and summarize one case of uveal melanoma following treatment of hematologic malignancies with Bruton's tyrosine kinase inhibitors.
Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya   +2 more
doaj  

Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor [PDF]

, 2011
Donald W. MacGlashan, Lee Honigberg, Ashley Smith, Joseph J. Buggy, John T. Schroeder   +4 more
openalex   +1 more source

Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors** [PDF]

, 2023
Chandra Prakash Koraboina, Venkatanarayana Chowdary Maddipati, Narendran Annadurai, Soňa Gurská, Petr Džubák, Marián Hajdúch, Viswanath Das, Rambabu Gundla   +7 more
openalex   +1 more source

Bruton’s tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia [PDF]

, 2018
AG Evans, B Mizukawa, FM Vega, G Pillinger, H Wu, HP Kuo, HS Kuehn, J Wei, K Bence, L Zaitseva, M Konopleva, MA Ayoub, MY Murray, R Schrage, S Tavor, SA Rushworth, SP Xu, T Oellerich, TL Gu   +18 more
core   +1 more source

Isoform of Bruton's tyrosine kinase (BTK) protein

, 2008
The use of compounds is described which are capable of functionally blocking at least one of the genes chosen from the group composed of EphA1, EphA2, EphA8, EphB2, CSF1R, VEGFR2, RAMP2, RAMP3, CLRN1, MAPK4, PIK3C2A, PIK3CG, GSK3alpha, GSK3beta, IRAK3, DAPK1, JAK1, PIM1, TRB3, BTG1, LATS1, LIMK2, MYLK, PAK1, PAK2, CDC2, BTK, PNRC2, NCOA4, NR2C1, TPR ...
LAVITRANO, MARIALUISA, GRASSILLI, EMANUELA, Helin, K.   +2 more
openaire   +2 more sources

A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase

The Turkish Journal of Pediatrics, 2006
X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the
Lütfiye Mesci, Hilal Ozdag, Tuba Turul, Fügen Ersoy, Ilhan Tezcan, Ozden Sanal   +5 more
doaj  

Bleeding Risk With Antiplatelets and Bruton's Tyrosine Kinase Inhibitors in Patients With Percutaneous Coronary Intervention. [PDF]

J Soc Cardiovasc Angiogr Interv, 2023
Mendez-Ruiz A, Lossos IS, Cohen MG.
europepmc   +1 more source

Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition

, 2001
Taku Kouro, Kisaburo Nagata, Satoshi Takaki, Sazuku Nisitani, Masayuki Hirano, Matthew I. Wahl, Owen N. Witte, Hajime Karasuyama, Kiyoshi Takatsu   +8 more
openalex   +1 more source